Join to View Full Profile
1217 E 10th AveAnchorage, AK 99501
Phone+1 907-257-4670
Fax+1 907-792-6546
Dr. Gessner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Washington School of Public Health and Community Medicine A Public Health and General Preventive MedicineResidency, Public Health and General Preventive Medicine, 1995 - 1997
University of ColoradoResidency, Pediatrics, 1988 - 1991
University of Florida College of MedicineClass of 1988
Certifications & Licensure
AK State Medical License 1994 - 2026
CO State Medical License 1991 - 1999
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 2 citationsRelative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States.Evan J Anderson, Ashley Tippett, Elizabeth Begier, Theda Gibson, Gabby Ess
The Journal of Infectious Diseases. 2024-12-16 - Association of Pneumococcal Conjugate Vaccination With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Older Adult Recipients of Coronavirus Disease 20...Joseph A Lewnard, Vennis Hong, Lindsay R Grant, Bradley K Ackerson, Katia J Bruxvoort
The Journal of Infectious Diseases. 2024-11-15 - 1 citationsEffect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature Review.Ingrid T Sepúlveda-Pachón, Eileen M Dunne, Germaine Hanquet, Marc Baay, Sonia Menon
The Journal of Infectious Diseases. 2024-09-23
Journal Articles
- Antibody Persistence at the Population Level 5 Years After Mass Vaccination with Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Boost...Bradford Gessner, MD, Clinical Infectious Diseases
Press Mentions
FDA-Approved RSV Maternal Vaccine Protects Infants, Reduces Economic BurdenOctober 21st, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
